MyFinsight
Home
Blog
About
Net loss
attributable to common...
-$12,701K
Net loss
attributable to...
-$120K
Net income (loss)
-$12,802K
(-21.23%↓ Y/Y)
Cumulative preferred
dividends allocated to...
$11K
Deemed dividend to
preferred stockholders
$8K
Net loss before
equity in net loss of...
-$12,802K
Income (loss) before
income tax expense
-$12,802K
(-21.23%↓ Y/Y)
Other income
(expense)
$378K
(17.39%↑ Y/Y)
Human Health Segment
$1,175K
Animal Health Segment
$50K
Income (loss) from
operations
-$7,597K
(5.12%↑ Y/Y)
Gain on
extinguishment of debt
-$3,504K
(-92.32%↓ Y/Y)
Changes in fair value of
freestanding and hybrid...
$1,918K
(79.59%↑ Y/Y)
Total revenue, net
$1,225K
(-58.88%↓ Y/Y)
Interest income
(expense)
$161K
(1173.33%↑ Y/Y)
Total operating
expenses
$8,822K
(-19.70%↓ Y/Y)
General and
administrative
$4,450K
(-5.86%↓ Y/Y)
Research and development
$3,336K
(2.17%↑ Y/Y)
Cost of product
revenue
$1,031K
(95.64%↑ Y/Y)
Sales and marketing
$5K
(-99.80%↓ Y/Y)
Back
Back
Income Statement
Jaguar Health, Inc. (JAGX)
Jaguar Health, Inc. (JAGX)
source: myfinsight.com